Viewing Study NCT05054166


Ignite Creation Date: 2025-12-24 @ 4:44 PM
Ignite Modification Date: 2025-12-29 @ 9:19 AM
Study NCT ID: NCT05054166
Status: COMPLETED
Last Update Posted: 2021-09-23
First Post: 2021-09-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy of Everolimus-containing Chemotherapy in HER2- mBC Patients With PI3K/AKT/mTOR Mutations Study
Sponsor: Zhejiang Cancer Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module